CB
Bridel, Claire
Affiliation entities
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
CSF protein ratios with enhanced potential to reflect Alzheimer's disease pathology and neurodegeneration | Molecular neurodegeneration | 2024 | 59 | 17 | |||
Clusters of co-abundant proteins in the brain cortex associated with fronto-temporal lobar degeneration | Alzheimer's research & therapy | 2023 | 47 | 7 | |||
Serum glial fibrillary acidic protein compared with neurofilament light chain as a biomarker for disease progression in multiple sclerosis | JAMA neurology | 2023 | 90 | 0 | |||
Optochiasmatic Tuberculoma and Arachnoiditis as a Paradoxical Reaction to Antituberculous Treatment | Journal of neuro-ophthalmology | 2023 | 34 | 0 | |||
Paraneoplastic Autoimmune Limbic Encephalitis Associated with an Atypical Carcinoid Tumor of the Lung : A Case Report | Case reports in neurology | 2023 | 89 | 27 | |||
A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients | Journal of magnetic resonance imaging | 2023 | 66 | 21 | |||
Biomarkers of disease progression in multiple sclerosis: towards measuring the forest behind the tree | 2023 | 104 | 129 | ||||
A bilateral aseptic pyogenic ventriculitis following a course of pembrolizumab, an anti-PD-1 immune checkpoint inhibitor treatment for metastatic small cell lung cancer | Thérapie | 2022 | 18 | 0 | |||
Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers | Brain : a journal of neurology | 2022 | 110 | 0 | |||
Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis | JAMA neurology | 2022 | 174 | 75 | |||
Plasma proteome profiling identifies changes associated to AD but not to FTD | Acta neuropathologica communications | 2022 | 100 | 16 | |||
Author Response: Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis | Neurology | 2022 | 134 | 36 | |||
Variations in consecutive serum neurofilament light levels in healthy controls and multiple sclerosis patients | Multiple sclerosis and related disorders | 2021 | 127 | 45 | |||
Ultrasensitive immunoassay allows measurement of serum neurofilament heavy in multiple sclerosis | Multiple sclerosis and related disorders | 2021 | 84 | 56 | |||
Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis | Neurology | 2021 | 98 | 189 | |||
Encéphalopathie aiguë et Covid-19: hypothèses physiopathologiques | Revue médicale suisse | 2021 | 194 | 170 | |||
Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach | Molecular neurodegeneration | 2020 | 138 | 69 | |||
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study | Multiple sclerosis | 2020 | 110 | 84 | |||
VGF Peptides in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies | International journal of molecular sciences | 2019 | 128 | 58 | |||
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis | JAMA neurology | 2019 | 83 | 1 | |||
Pre-analytical stability of novel cerebrospinal fluid biomarkers | Clinica chimica acta | 2019 | 210 | 0 | |||
No Plasmatic Proteomic Signature at Clinical Disease Onset Associated With 11 Year Clinical, Cognitive and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis Patients | Frontiers in molecular neuroscience | 2018 | 78 | 30 | |||
Brain endothelial cell expression of SPARCL-1 is specific to chronic multiple sclerosis lesions and is regulated by inflammatory mediators in vitro | Neuropathology and applied neurobiology | 2018 | 122 | 0 | |||
Regulator of oligodendrocyte maturation, miR-219, a potential biomarker for MS | Journal of neuroinflammation | 2017 | 124 | 38 | |||
Glutaminyl cyclase activity correlates with levels of Aβ peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer's disease patients | Alzheimer's research & therapy | 2017 | 124 | 50 | |||
A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients | Multiple sclerosis | 2015 | 610 | 1 | |||
Neurodegeneration and unfolded-protein response in mice expressing a membrane-tethered flexible tail of PrP | PloS one | 2015 | 84 | 60 | |||
Minimal supportive treatment in natalizumab-related PML in a MS patient | Journal of neurology, neurosurgery and psychiatry | 2015 | 501 | 0 | |||
A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-up | Journal of neuroimmunology | 2015 | 518 | 1 | |||
Hematologic modifications in natalizumab-treated multiple sclerosis patients: An 18-month longitudinal study | Neurology® neuroimmunology & neuroinflammation | 2015 | 454 | 298 | |||
Body fluid biomarkers for multiple sclerosis — the long road to clinical application | Nature reviews. Neurology | 2015 | 99 | 0 | |||
Teaching NeuroImages: Drug-induced parkinsonism with asymmetrical putaminal DaT binding | Neurology | 2015 | 471 | 0 | |||
Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of neurosarcoidosis | Journal of neuroimmunology | 2015 | 569 | 0 | |||
Multifocal motor neuropathy with high titers of anti-MAG antibodies | Journal of the peripheral nervous system | 2014 | 511 | 0 | |||
Update on multiple sclerosis treatments | Schweizerische medizinische Wochenschrift | 2014 | 467 | 1 | |||
Aerosols transmit prions to immunocompetent and immunodeficient mice | PLOS pathogens | 2011 | 46 | 13 | |||
Unexpected tolerance of alpha-cleavage of the prion protein to sequence variations | PloS one | 2010 | 46 | 13 | |||
Follicular dendritic cells control engulfment of apoptotic bodies by secreting Mfge8 | The journal of experimental medicine | 2008 | 40 | 23 |